查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1392088

威尔姆氏肿瘤（肾母细胞瘤）蛋白市场：依产品种类、依应用、依最终使用者、依检测方法、依阶段、按地区

Wilms Tumor Protein Market, By Product Type, By Application, By End User, By Detection Method (Immunohistochemistry, Enzyme-Linked Immunosorbent Assay, Western Blotting, Polymerase Chain Reaction, and Others), By Disease Stage, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 160 Pages | 商品交期: 2-3个工作天内

价格
简介目录

全球威尔姆氏肿瘤（肾母细胞瘤）蛋白市场预计将显着成长，到 2023 年美国将达到 29.2 亿美元。预计到 2030 年将继续扩大并达到 40 亿美元，预测期内年复合成长率(CAGR)为 4.6%。

报告范围 报告详情
基准年 2022年 2023年市场规模 29.2亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 4.60% 2030年市场规模预测 40亿美元
图 1.威尔姆氏肿瘤蛋白全球市场占有率(%)（按地区），2023 年
肾母细胞瘤蛋白市场-IMG1

威尔姆氏肿瘤蛋白是一种转录因子，在多种癌症的进展中发挥重要作用。它也被证明与化疗抗药性有关。因此， 威尔姆氏肿瘤蛋白被提议作为开发新型抗癌药物的有希望的标靶。根据 NCBI， 威尔姆氏肿瘤蛋白参与染色质重塑复合物并促进多个基因的表达。它已被证明与多种化疗药物相互作用，包括柔红霉素和米托蒽醌。

市场动态：

全球癌症患者数量的增加预计将在预测期内推动全球威尔姆氏肿瘤蛋白市场的成长。此外，人们对威尔姆氏肿瘤及其治疗和诊断的认识的提高预计也将推动预测期内全球威尔姆氏肿瘤蛋白市场的成长。根据美国癌症协会2020年1月发布的资料，威尔姆氏肿瘤是儿童肾癌的主要形式。美国每年报告 500 至 600 例新威尔姆氏肿瘤病例，这一数字随着时间的推移保持相对稳定。威尔姆氏肿瘤约占所有儿童癌症的 5%。

然而，诊断和治疗程序的高成本预计将阻碍预测期内全球威尔姆氏肿瘤蛋白市场的成长。诊断和治疗程序的高成本可能会严重阻碍全球威尔姆氏肿瘤蛋白市场的成长。昂贵的诊断测试和治疗方法可能会限制患者的就诊，特别是在医疗保健资源有限的地区。这种成本障碍可能会减少患者对威尔姆氏肿瘤蛋白相关治疗方法和诊断的采用，这可能会影响市场扩张以及覆盖更广泛患者群体的能力。

本研究的主要特点

  • 该报告对全球威尔姆氏肿瘤蛋白市场进行了详细分析，并提供了以2022年为基准年的预测期（2023-2030）的市场规模和年复合成长率（CAGR%）。
  • 它还揭示了各个细分市场的潜在商机，并为该市场说明了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据公司亮点、产品系列、主要亮点、绩效和策略等参数，介绍了全球威尔姆氏肿瘤蛋白市场的主要企业。
  • 该报告的见解使行销人员和经营团队负责人就未来的产品发布、类型升级、市场扩张和行销策略做出资讯的决策。
  • 威尔姆氏肿瘤蛋白全球市场报告针对该行业的各个相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球威尔姆氏肿瘤蛋白市场的各种策略矩阵，将促进相关人员的决策。

目录

第1章研究目的与前提

  • 研究目标
  • 假设
  • 简称

第2章市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第3章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
  • 威尔姆氏肿瘤治疗对标靶治疗的需求不断增加
  • 癌症诊断和治疗领域的技术发展
    • 抑制因素
  • 诊断和治疗费用昂贵
    • 机会
  • 威尔姆氏肿瘤研究经费增加
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第4章全球威尔姆氏肿瘤蛋白市场－冠状病毒（COVID-19）大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第5章全球威尔姆氏肿瘤蛋白市场，依产品类型，2018-2030

  • 抗体
  • 检测套件
  • 重组蛋白
  • 其他的

第6章全球威尔姆氏肿瘤蛋白市场，依应用分类，2018-2030

  • 癌症诊断
  • 癌症治疗
  • 研究与开发
  • 其他的

第7章全球威尔姆氏肿瘤蛋白市场，依最终用户划分，2018-2030 年

  • 医院
  • 诊断实验室
  • 研究机构
  • 其他的

第8章全球威尔姆氏肿瘤蛋白市场，依检测方法，2018-2030

  • 免疫组织化学 (IHC)
  • 酵素免疫分析法测定法 (ELISA)
  • 西方印渍术
  • 聚合酶炼式反应 (PCR)
  • 其他的

第9章2018-2030 年全球威尔姆氏肿瘤蛋白市场（按阶段）

  • 诊断
  • 监测/预测

第10章全球威尔姆氏肿瘤蛋白市场，依地区，2018-2030

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第11章竞争形势

  • Abcam plc.
  • Thermo Fisher Scientific, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Novus Biologicals, LLC
  • R&D Systems, Inc.（a subsidiary of Bio-Techne Corporation）
  • OriGene Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KGaA
  • BioLegend, Inc.
  • Genetex, Inc.（a subsidiary of Novus Biologicals, LLC）
  • Agilent Technologies, Inc.
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Boster Biological Technology
  • Fitzgerald Industries International

第12章章节

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5825

Global Wilms Tumor Protein Market experienced substantial growth, and is expected to be valued at US$ 2.92 billion in 2023. It is projected to continue expanding, reaching US$ 4 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 4.6% during the forecast period.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.92 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 4.60% 2030 Value Projection: US$ 4 Bn
Figure 1. Global Wilms Tumor Protein Market Share (%), by Region, 2023
Wilms Tumor Protein Market - IMG1

Wilms tumor protein is a transcription factor that plays an important role in the progression of various types of cancer. It has also been shown to be associated with resistance to chemotherapies. As a result, Wilms tumor protein has been proposed to be a promising target for the development of new anti-cancer drugs. According to NCBI, Wilms tumor protein is involved in the chromatin remodeling complex and promotes the expression of several genes. It has been shown to interact with several chemotherapeutic agents including daunorubicin and mitoxantrone.

Market Dynamics:

Increasing cancer cases worldwide is expected to drive growth of the global wilms tumor protein market over the forecast period. Moreover, increasing awareness regarding Wilms tumor and its treatment and diagnosis is also expected to propel growth of the global Wilms tumor protein market over the forecast period. According to the data published by American Cancer Society in January 2020, Wilms tumor stands as the predominant form of kidney cancer found in children. Annually, in the U.S., 500 to 600 new Wilms tumor cases are reported, a figure that has exhibited relatively consistent levels over an extended period. Wilms tumors account for approximately 5% of all childhood cancer cases.

However, high cost of diagnosis and treatment procedures is expected to hinder growth of the global Wilms tumor protein market over the forecast period. The high cost of diagnosis and treatment procedures can significantly hinder the growth of the global Wilms tumor protein market. Expensive diagnostic tests and treatments may limit accessibility for patients, particularly in regions with limited healthcare resources. This cost barrier could reduce patient uptake of Wilms tumor protein-related therapies and diagnostics, potentially impacting the market's expansion and inhibiting the ability to reach a broader patient population.

Key features of the study:

  • This report provides in-depth analysis of the global wilms tumor protein market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), considering 2022 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global wilms tumor protein market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Abcam plc, Thermo Fisher Scientific, Inc., Santa Cruz Biotechnology, Inc., Novus Biologicals, LLC, R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation), OriGene Technologies, Inc., Cell Signaling Technology, Inc., Merck KGaA, BioLegend, Inc., Genetex, Inc. (a subsidiary of Novus Biologicals, LLC), Agilent Technologies, Inc., Proteintech Group, Inc., Sino Biological Inc., Boster Biological Technology, and Fitzgerald Industries International
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global wilms tumor protein market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global wilms tumor protein market

Global Wilms Tumor Protein Market Detailed Segmentation:

  • By Product Type:
    • Antibodies
    • Assay Kits
    • Recombinant Proteins
    • Others
  • By Application:
    • Cancer Diagnosis
    • Cancer Treatment
    • Research and Development
    • Others
  • By End User:
    • Hospitals
    • Diagnostic Laboratories
    • Research Institutes
    • Others
  • By Detection Method:
    • Immunohistochemistry (IHC)
    • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Western Blotting
    • Polymerase Chain Reaction (PCR)
    • Others
  • By Disease Stage:
    • Diagnosis
    • Monitoring and Prognosis
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abcam plc
    • Thermo Fisher Scientific, Inc.
    • Santa Cruz Biotechnology, Inc.
    • Novus Biologicals, LLC
    • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
    • OriGene Technologies, Inc.
    • Cell Signaling Technology, Inc.
    • Merck KGaA
    • BioLegend, Inc.
    • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
    • Agilent Technologies, Inc.
    • Proteintech Group, Inc.
    • Sino Biological Inc.
    • Boster Biological Technology
    • Fitzgerald Industries International

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Wilms Tumor Protein, By Product Type
    • Market Wilms Tumor Protein, By Application
    • Market Wilms Tumor Protein, By End User
    • Market Wilms Tumor Protein, By Detection Method
    • Market Wilms Tumor Protein, By Disease Stage
    • Market Wilms Tumor Protein, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
  • Increasing demand for targeted therapies for Wilms tumor treatment
  • Technological developments in the field of cancer diagnostics and treatment
    • Restraints
  • High cost of diagnosis and treatment procedures
    • Opportunities
  • Growing funding for research on Wilms tumor
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Global Wilms Tumor Protein Market- Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Wilms Tumor Protein Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Antibodies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Assay Kits
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Recombinant Proteins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

6. Global Wilms Tumor Protein Market, By Application, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Cancer Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Cancer Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research and Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Global Wilms Tumor Protein Market, By End User, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Diagnostic Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Research Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

8. Global Wilms Tumor Protein Market, By Detection Method, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Immunohistochemistry (IHC)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,( US$ Bn)
  • Enzyme-Linked Immunosorbent Assay (ELISA)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Western Blotting
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Polymerase Chain Reaction (PCR)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

9. Global Wilms Tumor Protein Market, By Disease Stage, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2018 - 2030
    • Segment Trends
  • Diagnosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)
  • Monitoring and Prognosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030, (US$ Bn)

10. Global Wilms Tumor Protein Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, For Region, 2023-2030
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Detection Method, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Disease Stage, 2018-2030, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Sub-Region, 2018-2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

11. Competitive Landscape

  • Abcam plc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Novus Biologicals, LLC
  • R&D Systems, Inc. (a subsidiary of Bio-Techne Corporation)
  • OriGene Technologies, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KGaA
  • BioLegend, Inc.
  • Genetex, Inc. (a subsidiary of Novus Biologicals, LLC)
  • Agilent Technologies, Inc.
  • Proteintech Group, Inc.
  • Sino Biological Inc.
  • Boster Biological Technology
  • Fitzgerald Industries International
  • Analyst Views

12. Section

  • Research Methodology
  • About us